ATE267808T1 - Verfahren zur herstellung von 2,5- disubstituierten pyridinen - Google Patents

Verfahren zur herstellung von 2,5- disubstituierten pyridinen

Info

Publication number
ATE267808T1
ATE267808T1 AT98114969T AT98114969T ATE267808T1 AT E267808 T1 ATE267808 T1 AT E267808T1 AT 98114969 T AT98114969 T AT 98114969T AT 98114969 T AT98114969 T AT 98114969T AT E267808 T1 ATE267808 T1 AT E267808T1
Authority
AT
Austria
Prior art keywords
formula
compound
chem
signifies
producing
Prior art date
Application number
AT98114969T
Other languages
English (en)
Inventor
Paul Spurr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE267808T1 publication Critical patent/ATE267808T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/08Preparation by ring-closure
    • C07D213/09Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles
    • C07D213/10Preparation by ring-closure involving the use of ammonia, amines, amine salts, or nitriles from acetaldehyde or cyclic polymers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98114969T 1997-08-19 1998-08-10 Verfahren zur herstellung von 2,5- disubstituierten pyridinen ATE267808T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97114269 1997-08-19

Publications (1)

Publication Number Publication Date
ATE267808T1 true ATE267808T1 (de) 2004-06-15

Family

ID=8227241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98114969T ATE267808T1 (de) 1997-08-19 1998-08-10 Verfahren zur herstellung von 2,5- disubstituierten pyridinen

Country Status (10)

Country Link
US (1) US6080866A (de)
EP (1) EP0897914B1 (de)
JP (1) JP3025239B2 (de)
KR (1) KR100275663B1 (de)
CN (1) CN1103335C (de)
AT (1) ATE267808T1 (de)
CA (1) CA2245169C (de)
DE (1) DE69824090T2 (de)
DK (1) DK0897914T3 (de)
ES (1) ES2221696T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US6417360B1 (en) 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
ZA200002318B (en) * 1999-05-22 2000-11-16 Actelion Pharmaceuticals Ltd Aqueous pharmaceutical composition.
NZ599605A (en) * 2007-02-19 2013-11-29 Marinepolymer Tech Inc Hemostatic compositions and therapeutic regimens
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
EP3501284A1 (de) 2011-04-15 2019-06-26 Marine Polymer Technologies, Inc. Behandlung von haut-krankheiten mit poly-n-acetylglucosamin-nanofasern
JP2023548185A (ja) 2020-11-05 2023-11-15 イドーシア ファーマシューティカルズ リミテッド クラゾセンタン二ナトリウム塩の安定な結晶性水和物
KR20240121242A (ko) 2021-12-17 2024-08-08 넥세라 파마 씨오., 엘티디. 클라조센탄 디소듐 염, 이의 제조 및 이를 포함하는 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571683B2 (en) * 1984-05-23 1988-04-21 Zeneca Ag Products Inc. 2-substituted-5-methylpyridines from methylcyclobutane- carbonitrile, valeronitrile and pentenonitrile intermediates
DE4223013A1 (de) * 1992-07-13 1994-01-20 Bayer Ag Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
US5837708A (en) * 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
TW313568B (de) * 1994-12-20 1997-08-21 Hoffmann La Roche

Also Published As

Publication number Publication date
DK0897914T3 (da) 2004-09-27
CA2245169A1 (en) 1999-02-19
EP0897914B1 (de) 2004-05-26
CN1103335C (zh) 2003-03-19
JP3025239B2 (ja) 2000-03-27
KR19990023680A (ko) 1999-03-25
CN1210105A (zh) 1999-03-10
EP0897914A1 (de) 1999-02-24
KR100275663B1 (ko) 2000-12-15
DE69824090D1 (de) 2004-07-01
CA2245169C (en) 2004-08-10
ES2221696T3 (es) 2005-01-01
US6080866A (en) 2000-06-27
JPH11116554A (ja) 1999-04-27
DE69824090T2 (de) 2005-07-07

Similar Documents

Publication Publication Date Title
ATE223900T1 (de) Verfahren zur herstellung von 4- trifluormethylnicotinsäure
ATE145891T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-derivaten und ein zwischenproduckt dafür
DE69534029D1 (de) Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung
ATE117672T1 (de) Verfahren zur herstellung von nitrilen.
DE59502882D1 (de) Verfahren zur Herstellung von Benzyl-piperidylmethylindanonen
ATE267808T1 (de) Verfahren zur herstellung von 2,5- disubstituierten pyridinen
DK539589D0 (da) Fremgangsmaade til fremstilling af 3-oxo-4-azasteroider
ATE138376T1 (de) Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
TW357056B (en) Herbicides
DK1124805T3 (da) Fremgangsmåde til fremstilling af 4-[(2',5'-diamino-6'-halogenpyrimidin-4'-yl)amino]cyclopent-2-enylmethanoler
EP1010684A4 (de) Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DK0412529T3 (da) Hidtil ukendte imidazolderivater, fremgangsmåde til fremstilling deraf og midler mod mavesår indeholdende disse
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
DE69706504D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3-cyclobuten-1,2-dion
ATE223377T1 (de) Verfahren zur herstellung von difluoracetophenon- derivaten
ATE180769T1 (de) Verfahren zur herstellung von n-alkylacetamiden
ATE256113T1 (de) Verfahren zur herstellung von arylamiden heteroaromatischer carbonsäuren
ATE59375T1 (de) Verfahren zur herstellung von polyenaldehyden.
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE69834853D1 (de) 1H-pyrrolo i1,2-böi1,2,4ötriazolederivate, Zwischenprodukte und Verfahren zur Herstellung von 1H-1,2,4,-triazol-5-yl Essigsäureesterderivate
ATE244701T1 (de) Verfahren zur herstellung von arylsulfenylhalogeniden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0897914

Country of ref document: EP